Global Retinitis Pigmentosa Treatment Market Report By Type (Autosomal Recessive Inheritance, Autosomal Dominant Inheritance, X-Linked Inheritance), By Treatment Type (Drugs, Devices, Surgery), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2019-2026

ID:VMR11212336
May 2020
Report Formats:

The global demand for Retinitis Pigmentosa Treatment Market is presumed to reach the valuation of nearly USD XXX MN by 2026 from USD XXX MN in 2019 with a CAGR of X.XX% under the study period of 2020 - 2026.
 
Retinitis Pigmentosa (RP) is a group of rare inherited eye disorders, which involves serious vision impairment. It causes gradual degeneration of light-sensing cells or photoreceptor cells in the retina. The most common symptoms include a loss of peripheral vision and difficulty seeing at night. It gets initiated in early childhood and gradually progresses resulting in complete loss of vision. At present there is no treatment for RP, however, researchers are working hard to find an effective cure for the disease. Some combined treatment plans include the use of Vitamin A palmitate, lutein, and Docosahexaenoic acid (DHA). Sometimes acetazolamide is used to treat macular edema. The manufacturers are now concentrating on the application of retinal prosthesis devices to restore the lost vision. A new emerging technology, known as optogenetics, that applies gene therapy to restore vision, is presently being studied by a few of the companies.
 
Market Dynamics
 
The key market drivers of the global Retinitis Pigmentosa Treatment market include increasing number of patients, and increasing awareness and demand for the effective treatment plans, Furthermore, factors such as growing approvals by governments, growing R &D, and advancement in technology are also propelling the market. The global pandemic COVID-19 is boosting the overall R & D in the healthcare sector significantly. COVID-19 pandemic is likely to support the global Retinitis Pigmentosa Treatment market.
 
The report covers Porter’s Five Forces Model, Market Attractiveness Analysis and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level.
 
Additionally, these tools also give inclusive assessment of each application/product segment in the global market of retinitis pigmentosa treatment.
 
Market Segmentation
 
The entire retinitis pigmentosa treatment market has been sub-categorized into type, treatment type and distribution channel. The report provides an analysis of these subsets with respect to the geographical segmentation. This research study will keep marketer informed and helps to identify the target demographics for a product or service.
 
By Type

  • Autosomal Recessive Inheritance
  • Autosomal Dominant Inheritance
  • X-Linked Inheritance
 
By Treatment Type
  • Drugs
    • Vitamin A
    • Acetazolamide
    • Others
  • Devices
    • Sunglasses
    • Implants
  • Surgery
    • Retinal Transplantation
    • Corneal Neurotization
 
By Distribution Channel
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
 
Regional Analysis
 
This section covers regional segmentation which accentuates on current and future demand for retinitis pigmentosa treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand for individual application segment across all the prominent regions.
 
Europe Retinitis Pigmentosa Treatment Market By Revenue (USD MN)
 

 
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the retinitis pigmentosa treatment market include Orphagen Pharmaceuticals, Inc., Astellas Pharma, Inc., Clino Corporation, Caladrius, Spark Therapeutics, Inc., Genethon, Gensight Biologics, Grupo Ferrer International, S.A., InFlectis BioScience, Nanovector S.r.l., Ionis Pharmaceuticals, Inc., MeiraGTx Limited. This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
                                            
METHODOLOGY:
 
This market research report has been produced by gathering information on the basis of primary and secondary research. Secondary research has been done by using various sources which include (but not limited to) Company Websites, Paid Data Sources,  Technical Journals, Financial Reports, SEC Filings, and other different industry publications.
 
If specific information is required which is not currently within the scope of the report, it can be provided as a part of customization.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology
 
2 . EXECUTIVE SUMMARY
       2.1. Highlights of Retinitis Pigmentosa Treatment Market
       2.2. Global Retinitis Pigmentosa Treatment Market Snapshot
 
3 . RETINITIS PIGMENTOSA TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction
       3.2. Market Drivers of Retinitis Pigmentosa Treatment Market
       3.3. Market Restraints of Retinitis Pigmentosa Treatment Market
       3.4. Opportunities of Retinitis Pigmentosa Treatment Market
       3.5. Trends of Retinitis Pigmentosa Treatment Market
       3.6. Porter’s Five Force Analysis of Retinitis Pigmentosa Treatment Market
       3.7. Retinitis Pigmentosa Treatment Market Attractiveness Analysis
           3.7.1 Market Attractive Analysis by Type
           3.7.2 Market Attractive Analysis by Treatment Type
           3.7.3 Market Attractive Analysis by Distribution Channel
           3.7.4 Market Attractive Analysis by Region
 
4 . VALUE CHAIN ANALYSIS
       4.1. Retinitis Pigmentosa Treatment Value Chain Analysis
       4.2. Retinitis Pigmentosa Treatment Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Retinitis Pigmentosa Treatment Raw Material Manufactures List
           4.2.3. Price Trend of Retinitis Pigmentosa Treatment Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend
 
5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak on Retinitis Pigmentosa Treatment Market
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Retinitis Pigmentosa Treatment Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Retinitis Pigmentosa Treatment Market Size in 2020, by Scenario
       5.5. COVID-19: Micro and Macro Factor Analysis on Retinitis Pigmentosa Treatment Market
 
6 . GLOBAL RETINITIS PIGMENTOSA TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Global Retinitis Pigmentosa Treatment Market Analysis by Type
       6.3 Market Analysis of Autosomal Recessive Inheritance by Regions
       6.4 Market Analysis of Autosomal Dominant Inheritance by Regions
       6.6 Market Analysis of X-Linked Inheritance by Regions
 
7 . GLOBAL RETINITIS PIGMENTOSA TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
       7.1 Overview by Treatment Type
       7.2 Global Retinitis Pigmentosa Treatment Market Analysis by Treatment Type
       7.3 Market Analysis of Drugs by Regions
       7.4 Market Analysis of Devices by Regions
       7.5 Market Analysis of Surgery by Regions
 
8 . GLOBAL RETINITIS PIGMENTOSA TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       8.1 Overview by Distribution Channel
       8.2 Global Retinitis Pigmentosa Treatment Market Analysis by Distribution Channel
       8.3 Market Analysis of Hospital Pharmacies by Regions
       8.4 Market Analysis of Retail Pharmacies by Regions
       8.5 Market Analysis of Online Pharmacies by Regions
 
9 . GLOBAL RETINITIS PIGMENTOSA TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       9.1. Regional Outlook
       9.2. Introduction
       9.3. North America
           9.3.1. Overview
           9.3.2. North America Retinitis Pigmentosa Treatment Market Estimate by Country
           9.3.3. United State
           9.3.4. Rest of North America
       9.4. Europe
           9.4.1. Overview
           9.4.2. Europe Retinitis Pigmentosa Treatment Market Estimate by Market Segment
           9.4.3. Europe Retinitis Pigmentosa Treatment Market Estimate by Country
           9.4.4. United Kingdom
           9.4.5. France
           9.4.6. Germany
           9.4.7 Rest of Europe
       9.5. Asia Pacific
           9.5.1. Overview
           9.5.2. Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Market Segment
           9.5.3. Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Country
           9.5.4. China
           9.5.5. Japan
           9.5.6. India
           9.5.7. Rest of Asia Pacific
       9.6. Latin America
           9.6.1. Overview
           9.6.2. Latin America Retinitis Pigmentosa Treatment Market Estimate by Market Segment
           9.6.3. Latin America Retinitis Pigmentosa Treatment Market Estimate by Country
           9.6.4. Brazil
           9.6.5. Rest of Latin America
       9.7. Middle East & Africa
           9.7.1. Overview
           9.7.2. Middle East & Africa Retinitis Pigmentosa Treatment Market Estimate by Market Segment
           9.7.3. Middle East & Africa Retinitis Pigmentosa Treatment Market Estimate by Country
           9.7.4. Middle East
           9.7.5. Africa
 
10 . COMPETITIVE LANDSCAPE OF THE RETINITIS PIGMENTOSA TREATMENT COMPANIES
       10.1. Retinitis Pigmentosa Treatment Market Competition
       10.2. Partnership/Collaboration/Agreement
       10.3. Merger And Acquisitions
       10.4. New Product Launch
       10.5. Other Developments
 
11 . COMPANY PROFILES OF RETINITIS PIGMENTOSA TREATMENT INDUSTRY
       11.1. Company Share Analysis
       11.2. Market Concentration Rate
       11.3. Orphagen Pharmaceuticals, Inc.
           11.3.1. Company Overview
           11.3.2. Financials
           11.3.3. Products
           11.3.4. Recent Developments
       11.4. Astellas Pharma, Inc.
           11.4.1. Company Overview
           11.4.2. Financials
           11.4.3. Products
           11.4.4. Recent Developments
       11.5. Clino Corporation
           11.5.1. Company Overview
           11.5.2. Financials
           11.5.3. Products
           11.5.4. Recent Developments
       11.6. Caladrius, Spark Therapeutics, Inc.
           11.6.1. Company Overview
           11.6.2. Financials
           11.6.3. Products
           11.6.4. Recent Developments
       11.7. Genethon
           11.7.1. Company Overview
           11.7.2. Financials
           11.7.3. Products
           11.7.4. Recent Developments
       11.8. Gensight Biologics
           11.8.1. Company Overview
           11.8.2. Financials
           11.8.3. Products
           11.8.4. Recent Developments
       11.9. Grupo Ferrer International, S.A.
           11.9.1. Company Overview
           11.9.2. Financials
           11.9.3. Products
           11.9.4. Recent Developments
       11.10. InFlectis BioScience
           11.10.1. Company Overview
           11.10.2. Financials
           11.10.3. Products
           11.10.4. Recent Developments
       11.11. Nanovector S.r.l
           11.11.1. Company Overview
           11.11.2. Financials
           11.11.3. Products
           11.11.4. Recent Developments
       11.12. Ionis Pharmaceuticals, Inc.
           11.12.1. Company Overview
           11.12.2. Financials
           11.12.3. Products
           11.12.4. Recent Developments
       11.13. MeiraGTx Limited
           11.13.1. Company Overview
           11.13.2. Financials
           11.13.3. Products
           11.13.4. Recent Developments
 
 *Note - In company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies
 
LIST OF TABLES

  • Global Retinitis Pigmentosa Treatment Market Snapshot
  • Drivers of The Global Retinitis Pigmentosa Treatment Market Impact Analysis
  • Restraints of The Global Retinitis Pigmentosa Treatment Market Impact Analysis
  • List of Raw Material
  • List of Raw Material Manufactures
  • List of Potential Buyers
  • COVID-19 Impact Analysis by Production, Import, Export and Demand
  • Retinitis Pigmentosa Treatment Market: Pre V/S Post COVID-19
  • Estimated Impact Of The Coronavirus (Covid-19) Epidemic On The Retinitis Pigmentosa Treatment Market Size In 2020, By Scenario
  • COVID-19: Micro and Macro Factor Analysis on Retinitis Pigmentosa Treatment Market
  • Global Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Autosomal Recessive Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Autosomal Dominant Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in X-Linked Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis by Treatment Type (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Drugs by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Devices by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Surgery by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market by Geography (USD MN)
  • North America Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • North America Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • North America Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • North America Retinitis Pigmentosa Treatment Market Estimate by Country (USD MN)
  • United State Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • United State Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • United State Retinitis Pigmentosa Treatment Market Analysis by Distribution Channel (USD MN)
  • Rest of North America Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Rest of North America Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Rest of North America Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel(USD MN)
  • Europe Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Europe Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Europe Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • United Kingdom Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • United Kingdom Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • United Kingdom Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • France Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • France Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • France Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Germany Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Germany Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Germany Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Europe Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Rest of Europe Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Rest of Europe Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Country (USD MN)
  • China Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • China Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • China Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Japan Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Japan Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Japan Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • India Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • India Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • India Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Asia Pacific Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Rest of Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Rest of Asia Pacific Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Latin America Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Latin America Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Latin America Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Latin America Retinitis Pigmentosa Treatment Market Estimate by Country (USD MN)
  • Brazil Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Brazil Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Brazil Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Rest of Latin America Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Rest of Latin America Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Rest of Latin America Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Middle East & Africa Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Middle East & Africa Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Middle East & Africa Retinitis Pigmentosa Treatment Market Estimate by Country (USD MN)
  • Middle East Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Middle East Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Middle East Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Africa Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Africa Retinitis Pigmentosa Treatment Market Estimate by Treatment Type (USD MN)
  • Africa Retinitis Pigmentosa Treatment Market Estimate by Distribution Channel (USD MN)
  • Partnership/Collaboration/Agreement
  • Mergers And Acquisiton
  • New Product Launch
  • Other Developments
  • Company Market Share Analysis, 2019
 
LIST OF FIGURES
 
  • Research Scope of Retinitis Pigmentosa Treatment Report
  • Market Research Process
  • Market Research Methodology
  • Global Retinitis Pigmentosa Treatment Market Size, by Region (USD MN)
  • Porters Five Forces Analysis
  • Market Attractiveness Analysis by Type
  • Market Attractiveness Analysis by Treatment Type
  • Market Attractiveness Analysis by Distribution Channel
  • Market Attractiveness Analysis by Region
  • Value Chain Analysis
  • Global Retinitis Pigmentosa Treatment Market Analysis by Type (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Autosomal Recessive Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Autosomal Dominant Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in X-Linked Inheritance by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis by Treatment Type (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Drugs by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Devices by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Surgery by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis by Distribution Channel (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Hospital Pharmacies by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Retail Pharmacies by Geography (USD MN)
  • Global Retinitis Pigmentosa Treatment Market Analysis in Online Pharmacies by Geography (USD MN)
  • Latin America Retinitis Pigmentosa Treatment Market by Revenue
  • Middle East & Africa Retinitis Pigmentosa Treatment Market by Revenue
  • Recent Development in Retinitis Pigmentosa Treatment Industry
  • Company Market Share Analysis, 2019
 
* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Objectives of Study

  • Define and measure the global market
  • Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
  • Analyze and identify major market trends along with the factors driving or inhibiting the market growth
  • Study the company profiles of the major market players with their market share
  • Analyze competitive developments

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

  • Buy sections of this report
  • Buy country level reports
  • Request for historical data
  • Request discounts available for Start-Ups & Universities

Why Choose Us

Client First Policy
Excellent Quality
Robust After Sales Support
24/7 Email Support

Clients

Testimonials